Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285820281> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W4285820281 endingPage "143" @default.
- W4285820281 startingPage "139" @default.
- W4285820281 abstract "The oncotype DX recurrence score (ODX-RS) is a validated 21-gene assay that can quantify the recurrence risk and assess the likelihood of adjuvant chemotherapy benefit in breast cancer. The presence of lymphovascular invasion (LVI) in breast cancer patients is regarded as a predictor for worse prognosis. This study sought to explore the association of ODX-RS with LVI in oestrogen receptor-positive, human epidermal growth factor receptor-2-negative, low-burden nodal disease, early breast cancer.After clinical improvement unit approval, an institutional database was queried to identify the breast cancer cases diagnosed in the period between 2017-2021 that fulfilled the inclusion criteria. The total resected tumours comprised 107 in 102 patients (5 patients had bilateral disease). The data related to patients' age and tumour grade, LVI detection, nodal status, and ODX-RS were analysed.Lymphovascular invasion was identified in 32.6% of 107 tumours. In the age group > 50 years, 13 tumours had lymphovascular invasion (LVI +ve), 9 tumours had ODX-RS < 15 (69%), and only one tumour (8%) had ODX-RS ≤ 25, and this is associated with substantial chemotherapy benefit. In the age group ≤ 50 years, 21 tumours were LVI +ve, and 18 tumours had ODX-RS ≤ 25 (86%), which is associated with no chemotherapy benefit; only 3 tumours (14%) had ODX-RS > 25, and this indicated substantial chemotherapy benefit.This study revealed that in the targeted patient population lympho-vascular invasion did not have a statistically significant impact on ODX-RS (p = 0.29)." @default.
- W4285820281 created "2022-07-19" @default.
- W4285820281 creator A5008923284 @default.
- W4285820281 creator A5015624650 @default.
- W4285820281 creator A5027974318 @default.
- W4285820281 date "2022-01-01" @default.
- W4285820281 modified "2023-10-14" @default.
- W4285820281 title "Lymphovascular invasion in hormone-positive, human epidermal growth factor-negative, low-burden axillary disease in early breast cancer patients tested for oncotype DX recurrence score" @default.
- W4285820281 cites W1545734177 @default.
- W4285820281 cites W1980046023 @default.
- W4285820281 cites W1982431718 @default.
- W4285820281 cites W2032792437 @default.
- W4285820281 cites W2065552650 @default.
- W4285820281 cites W2097016282 @default.
- W4285820281 cites W2113344831 @default.
- W4285820281 cites W2118782378 @default.
- W4285820281 cites W2127504431 @default.
- W4285820281 cites W2160377567 @default.
- W4285820281 cites W2167177168 @default.
- W4285820281 cites W2408811526 @default.
- W4285820281 cites W2805734855 @default.
- W4285820281 cites W2883615655 @default.
- W4285820281 cites W2885663340 @default.
- W4285820281 cites W2893602527 @default.
- W4285820281 cites W2898958886 @default.
- W4285820281 cites W2899814155 @default.
- W4285820281 cites W2938054231 @default.
- W4285820281 cites W2948923376 @default.
- W4285820281 cites W2980523945 @default.
- W4285820281 cites W2991666586 @default.
- W4285820281 cites W3128646645 @default.
- W4285820281 cites W3216570310 @default.
- W4285820281 cites W98698319 @default.
- W4285820281 doi "https://doi.org/10.5114/wo.2022.118220" @default.
- W4285820281 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35903213" @default.
- W4285820281 hasPublicationYear "2022" @default.
- W4285820281 type Work @default.
- W4285820281 citedByCount "5" @default.
- W4285820281 countsByYear W42858202812022 @default.
- W4285820281 countsByYear W42858202812023 @default.
- W4285820281 crossrefType "journal-article" @default.
- W4285820281 hasAuthorship W4285820281A5008923284 @default.
- W4285820281 hasAuthorship W4285820281A5015624650 @default.
- W4285820281 hasAuthorship W4285820281A5027974318 @default.
- W4285820281 hasBestOaLocation W42858202811 @default.
- W4285820281 hasConcept C121608353 @default.
- W4285820281 hasConcept C126322002 @default.
- W4285820281 hasConcept C143998085 @default.
- W4285820281 hasConcept C2776694085 @default.
- W4285820281 hasConcept C2778740770 @default.
- W4285820281 hasConcept C2779013556 @default.
- W4285820281 hasConcept C2779134260 @default.
- W4285820281 hasConcept C29456083 @default.
- W4285820281 hasConcept C530470458 @default.
- W4285820281 hasConcept C71924100 @default.
- W4285820281 hasConceptScore W4285820281C121608353 @default.
- W4285820281 hasConceptScore W4285820281C126322002 @default.
- W4285820281 hasConceptScore W4285820281C143998085 @default.
- W4285820281 hasConceptScore W4285820281C2776694085 @default.
- W4285820281 hasConceptScore W4285820281C2778740770 @default.
- W4285820281 hasConceptScore W4285820281C2779013556 @default.
- W4285820281 hasConceptScore W4285820281C2779134260 @default.
- W4285820281 hasConceptScore W4285820281C29456083 @default.
- W4285820281 hasConceptScore W4285820281C530470458 @default.
- W4285820281 hasConceptScore W4285820281C71924100 @default.
- W4285820281 hasIssue "2" @default.
- W4285820281 hasLocation W42858202811 @default.
- W4285820281 hasLocation W42858202812 @default.
- W4285820281 hasLocation W42858202813 @default.
- W4285820281 hasOpenAccess W4285820281 @default.
- W4285820281 hasPrimaryLocation W42858202811 @default.
- W4285820281 hasRelatedWork W2348231456 @default.
- W4285820281 hasRelatedWork W2354050160 @default.
- W4285820281 hasRelatedWork W2367105124 @default.
- W4285820281 hasRelatedWork W2367923615 @default.
- W4285820281 hasRelatedWork W2368979736 @default.
- W4285820281 hasRelatedWork W2369039771 @default.
- W4285820281 hasRelatedWork W2379151083 @default.
- W4285820281 hasRelatedWork W2388730008 @default.
- W4285820281 hasRelatedWork W2782589310 @default.
- W4285820281 hasRelatedWork W2791179561 @default.
- W4285820281 hasVolume "26" @default.
- W4285820281 isParatext "false" @default.
- W4285820281 isRetracted "false" @default.
- W4285820281 workType "article" @default.